Drug interventions versus placebo for the treatment of Raynaud’s phenomenon: generic protocol

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the benefits and harms of the available pharmacological interventions compared to placebo for the treatment of Raynaud's phenomenon.

This is a protocol.

Health topics:

Rheumatology > Systemic sclerosis

Published:

18 May 2021

Authors:

Rirash F, Tingey PC, Harding SE, Maxwell LJ, Tanjong Ghogomu E, Maltez N, Tugwell P, Wells GA, Pope J

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Rirash F, Tingey PC, Harding SE, Maxwell LJ, Tanjong Ghogomu E, Maltez N, Tugwell P, Wells GA, Pope J. Drug interventions versus placebo for the treatment of Raynaud’s phenomenon: generic protocol (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD011813. DOI: 10.1002/14651858.CD011813.pub2.